Neoflubin
Recall
|
Medicines
|
19/09/2016
In a letter dated 19.09.2016, the marketing authorization holder informed its customers that yellow-brownish particles had been detected in the above batch and that a recall was therefore being carried out. The particles are traces of corrosion caused by an unsuitable connecting piece during filling.
| Name of the medicinal product | Neoflubin 25 mg/ml Konzentrat zur Herstellung einer Injektions-oder Infusionslösung |
|---|---|
| Marketing authorisation number(s) | 1-27630 |
| Marketing authorisation holder | EBEWE Pharma Ges.m.b.H. Nfg.KG Durchführung Rückruf: Sandoz GmbH |
| Batch number(s) | EJ2288 |
| Classification of the recall | 2 |
| BASG reference number | INS - 640.001 - 1828 |
Further inquiry note
Page last modified:
12/07/2022